What is your brain tumor story? Click here to share it. Your story matters.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
by Ben Stein-Lobovits I had it all—a marriage, a new dog, a house. Then, just a week before my 32nd birthday, I was diagnosed with a high-grade brainstem glioma. I
Get tips for optimizing what you eat during brain tumor treatment and in recovery.
**Sponsored Content**
Discover how Mayo Clinic is leveraging minimally invasive surgical techniques to maximize tumor resection while making recovery easier for patients.
From groundbreaking research to new collaborations at a federal level, discover the top three brain tumor news highlights and milestones for the year.
A first-in-class targeted therapy for low-grade glioma could gain FDA approval as early as spring 2024. Here are three things you should know about the emerging drug “vorasidenib.”
ABTA Founder Susan Kramer reflects on the last 50 years and her unrelenting pursuit toward finding a cure.
As we welcome 2023, it’s a time to embrace the new year and new ways to get involved and make an impact in the brain tumor community.
Meet two researchers on opposite ends of the globe dedicated to transforming the future of brain tumor treatments.
Albert Lai, MD, PhD is leading a UCLA research lab for primary brain tumors, including high grade gliomas and glioblastoma. But he credits the launch of his career with the ABTA. Learn how your donations can help jumpstart a brain tumor researcher’s career.
Always free for patients & caregivers
